Evidence map›Paper›PMID 25035427›Full record

ArticleThe Journal of biological chemistry2014

Identification of the docking site between a type III secretion system ATPase and a chaperone for effector cargo.

Sarah E Allison, Brian R Tuinema, Ellen S Everson, Seiji Sugiman-Marangos, Kun Zhang, Murray S Junop, Brian K Coombes

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Type III Secretion inMicrobiology and molecular biology reviews : MMBR · 2023
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. The T3SS ofMicroorganisms · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sarah E AllisonFrom the Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8S 4K1, Canada and the Michael G. DeGroote Institute for Infectious Disease Research, Hamilton, Ontario L8S 4K1, Canada.
Brian R TuinemaFrom the Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8S 4K1, Canada and the Michael G. DeGroote Institute for Infectious Disease Research, Hamilton, Ontario L8S 4K1, Canada.
Ellen S EversonFrom the Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8S 4K1, Canada and the Michael G. DeGroote Institute for Infectious Disease Research, Hamilton, Ontario L8S 4K1, Canada.
Seiji Sugiman-MarangosFrom the Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8S 4K1, Canada and the Michael G. DeGroote Institute for Infectious Disease Research, Hamilton, Ontario L8S 4K1, Canada.
Kun ZhangFrom the Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8S 4K1, Canada and the Michael G. DeGroote Institute for Infectious Disease Research, Hamilton, Ontario L8S 4K1, Canada.
Murray S JunopFrom the Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8S 4K1, Canada and the Michael G. DeGroote Institute for Infectious Disease Research, Hamilton, Ontario L8S 4K1, Canada.
Brian K CoombesFrom the Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8S 4K1, Canada and the Michael G. DeGroote Institute for Infectious Disease Research, Hamilton, Ontario L8S 4K1, Canada coombes@mcmaster.ca.
McMaster University · CA

Funding

Canadian Institutes of Health Research MOP 82704
6 · The paper itself

Abstract

A number of Gram-negative pathogens utilize type III secretion systems (T3SSs) to inject bacterial effector proteins into the host. An important component of T3SSs is a conserved ATPase that captures chaperone-effector complexes and energizes their dissociation to facilitate effector translocation. To date, there has been limited work characterizing the chaperone-T3SS ATPase interaction despite it being a fundamental aspect of T3SS function. In this study, we present the 2.1 Å resolution crystal structure of the Salmonella enterica SPI-2-encoded ATPase, SsaN. Our structure revealed a local and functionally important novel feature in helix 10 that we used to define the interaction domain relevant to chaperone binding. We modeled the interaction between the multicargo chaperone, SrcA, and SsaN and validated this model using mutagenesis to identify the residues on both the chaperone and ATPase that mediate the interaction. Finally, we quantified the benefit of this molecular interaction on bacterial fitness in vivo using chromosomal exchange of wild-type ssaN with mutants that retain ATPase activity but no longer capture the chaperone. Our findings provide insight into chaperone recognition by T3SS ATPases and demonstrate the importance of the chaperone-T3SS ATPase interaction for the pathogenesis of Salmonella.

Indexed as

Adenosine TriphosphatasesAnimalsBinding SitesCrystallizationFemaleMiceMice, Inbred C57BLMolecular ChaperonesMolecular Docking SimulationVirulenceAdenosine TriphosphatasesMolecular ChaperonesATPaseChaperoneCrystal StructureMicrobiologyType III Secretion System (T3SS)

Identifiers

PMID25035427
PMCPMC4156099
OpenAlexW2032471498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.